Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma. uri icon

authors

  • Bici, Anisa
  • Pianko, Matthew J
  • Nachar, Victoria R

publication date

  • January 1, 2022